News

Rare Earths Americas, Inc. filed its quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the period ended September 30, 2026, disclosing a significant change in its balance sheet following equity activity during the nine months ended September 30, 2026.

Corbus Pharmaceuticals Holdings, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing a nine-month net loss of $95.76 million and significantly higher operating expenses driven by expanded research and development activity.

Big Sky Industrial Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 10, 2026, reporting a significant expansion of its balance sheet driven by growth in unproved industrial gas properties and a …

Big Sky Industrial Inc. filed a Form 8-K with the SEC on November 10, 2026, announcing that it had issued a press release covering its financial results for the three and nine months ended September 30, 2026.

Inhibikase Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 10, 2026, covering the fiscal quarter ended September 30, 2026.

iBio, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 10, 2026, covering the quarterly period ended September 30, 2026, reporting a net loss of $7,551 thousand and total assets of $88,651 thousand.

Evolution Petroleum Corporation filed a Form 8-K on November 10, 2026, disclosing its financial and operating results for the quarter ended September 30, 2026, and announcing a $0.12 per common share dividend approved on November 9, 2026.